Top Markets
Coin of the day
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR
Rang in Aktien #36561
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Aktienkurs
$1.73
Zuletzt synchronisiert: 2025-06-17
Marktkapitalisierung
$2.55M
Veränderung (1 Tag)
-0.29%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Eiger BioPharmaceuticals, Inc. (EIGR)

Kategorie

Preis EIGR mit Marktkapitalisierung von B
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
EIGR
$1.73
Marktkapitalisierung von Eiger BioPharmaceuticals, Inc.(EIGR)
Marktkapitalisierung: $2.55M
Mit Stand August 2026 hat Eiger BioPharmaceuticals, Inc. eine Marktkapitalisierung von $2.55M. Das macht Eiger BioPharmaceuticals, Inc. laut unseren Daten zum 36561st wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Eiger BioPharmaceuticals, Inc. von 2014 bis 2026
EIGR im Vergleich zu den Top 5 der beliebtesten stocks
Preis für EIGR Vermögenswert B Marktkapitalisierung von B Ergebnisse
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$3,684,828 $2.55M
$5.452T +213,613,124.72%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$3,034,731 $2.55M
$4.490T +175,926,341.05%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$2,813,303 $2.55M
$4.162T +163,089,914.17%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$2,484,780 $2.55M
$3.676T +144,045,097.36%
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.
$1,914,807 $2.55M
$2.833T +111,003,211.28%